Hacke, W.

stroke patient lubeluzole group trial treatment placebo score ischemic ischemic stroke dclhb study placebo group safety swets subs service lubeluzole group rankin barthel inclusion outcome population phase effect event window efficacy 3 months ͼ75 years scale hemoglobin number 6 hours blood heart table difference placebo groups barthel index week 12 result analysis 2 treatment groups baseline symptom ischemic stroke patients neurology cerebrovasc dis blood pressure 5 days diener index rankin scale onset diaspirin cross-linked hemoglobin value rankin score 1 patient ischaemic stroke ct scan university mortality neuroprotective death month infusion service pressure trial medication stroke trial downloaded february 8 hours core stroke patients status inclusion time stratum baxter healthcare corp keyser j diaspirin core patients 18 hours